Therapy of non-small cell lung cancer in stage IV

被引：1
|
作者：
Deppermann, Karl-Matthias [1 ]
Huber, Rudolf M.
Laack, Eckart
Reck, Martin
Serke, Monika
von Pawel, Joachim
机构：
[1] Ruppiner Klinikum GmbH, Klin Pneumol, Neuruppin, Germany
[2] Univ Munich, Med Klin Innenstadt, D-8000 Munich, Germany
[3] Univ Hamburg, Klinikum Eppendorf, Med Klin 2, Hamburg, Germany
[4] Krankenhaus Grosshansdorf, Zentrum Pneumol & Thoraxchirurg, D-2070 Grosshansdorf, Germany
[5] Helios Klinikum Emil von Behring, Klin Pneumol 2, Lungenklin Heckeshorn, Berlin, Germany
[6] Asklepios Fachkliniken Munchen Gauting, Schwerpunkt Onkol, Gauting, Germany
来源：
ONKOLOGIE | 2006年 / 29卷
关键词：
NSCLC; pharmacology; erlotinib; combination therapy; single agent therapy;
D O I：
10.1159/000094950
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 19
页数：5
相关论文
共 50 条
  • [31] The effect of alcoholism on the prognosis of stage III and IV non-small cell lung cancer
    Paull, DE
    Updyke, GM
    Pacheco, J
    Chin, HW
    Baumann, M
    Adebonojo, SA
    CHEST, 2004, 126 (04) : 769S - 770S
  • [32] Use of chemotherapy for patients with stage IV non-small cell lung cancer.
    Waqar, Sadaf Huma
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha
    Gao, Feng
    Robinson, Cliff Grant
    Puri, Varun
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Detection of circulating tumor cells in stage IV non-small cell lung cancer
    Shishido, Stephanie N.
    Bazhenova, Lyudmila
    Carlsson, Anders
    Hicks, James
    Kuhn, Peter
    CANCER RESEARCH, 2017, 77
  • [34] Prognostic Implications of Timing of Immunotherapy in Stage IV Non-Small Cell Lung Cancer
    Vazquez-Urrutia, Jorge Raul
    Greenberg, Max
    Zhu, Junjia
    Takamori, Shinkichi
    Komiya, Takefumi
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (05) : 769 - 776
  • [35] Surgery in Stage IV Non-small Cell Lung Cancer: Good Time for a Chance
    Aprile, Vittorio
    Ambrogi, Marcello Carlo
    Lucchi, Marco
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 4847 - 4848
  • [36] Long-term survivors in stage IV non-small cell lung cancer
    Okamoto, T
    Maruyama, R
    Shoji, F
    Asoh, H
    Ikeda, J
    Miyamoto, T
    Nakamura, T
    Miyake, T
    Ichinose, Y
    LUNG CANCER, 2005, 47 (01) : 85 - 91
  • [37] Modern treatment approaches for patients with IV stage of non-small cell lung cancer
    Kadzhoyan, A. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2013, (03) : 79 - 83
  • [38] An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancer
    Evans, WK
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 82 - 89
  • [39] CHEMOTHERAPY IN STAGE IIIB AND IV NON-SMALL CELL LUNG CANCER: PROGNOSTIC FACTORS
    Racil, H.
    Rouhou, S. Cheikh
    Tlili, F.
    Zarrouk, M.
    Chaouch, N.
    Chabbou, A.
    LUNG CANCER, 2009, 64 : S58 - S58
  • [40] Early mortality of stage IV non-small cell lung cancer in the United States
    Amini, Arya
    Verma, Vivek
    Glaser, Scott M.
    Shinde, Ashwin
    Sampath, Sagus
    Stokes, William A.
    Rusthoven, Chad G.
    Massarelli, Erminia
    Salgia, Ravi
    Gaspar, Laurie E.
    Liu, Arthur K.
    ACTA ONCOLOGICA, 2019, 58 (08) : 1095 - 1101
12345